Apolipoprotein C3 (-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population

Table 4 Correlation between Apolipoprotein C3 (-455T>C) polymorphism and hypertension, dyslipidemia in the nonalcoholic fatty liver disease group n (%)

Genotype	Metabolic component		P value	Adjusted OR (95%CI)
	Non-hypertension	Hypertension
TT	82 (34.7)	12 (18.8)	-	1
TC	102 (43.2)	29 (45.3)	0.041	2.16 (1.02-4.57)1
CC	52 (22.1)	23 (35.9)	0.0032	3.42 (1.53-7.60)2
	Non-hypertriglyceridemia	Hypertriglyceridemia
TT	71 (39.3)	23 (19.3)	-	1
TC	77 (42.5)	54 (45.4)	0.021	2.03 (1.12-3.68)1
CC	33 (18.2)	42 (35.3)	< 0.0012	3.80 (1.95-7.41)2
	Normal HDL	Low HDL
TT	63 (36.6)	31 (24.2)	-	1
TC	75 (43.6)	56 (43.8)	0.301	1.36 (0.76 -2.42)1
CC	34 (19.8)	41 (32.0)	0.012	2.34 (1.21 -4.52)2
	Non-hypercholesterolemia	Hypercholesterolemia
TT	57 (32.0)	37 (30.3)	-	1
TC	81 (45.5)	50 (41.0)	0.521	-
CC	40 (22.5)	35 (28.7)	0.202	-
	Normal LDL	Increased LDL
TT	65 (31.0)	29 (32.2)	-	1
TC	89 (42.3)	42 (46.7)	0.411	-
CC	56 (26.7)	19 (21.1)	0.332	-

¹TC vs TT;

²CC vs TT. HDL: High-density lipoprotein cholesterol; LDL: Low-density lipoprotein cholesterol.